UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Therapie der Psoriasis vulgaris: Therapiestrategien für eine optimale patientenzentrierte Versorgung

Die Dermatologie, 2024-05, Vol.75 (5), p.417-427

2024

Link zum Volltext

Verfügbarkeit prüfen

Psoriasis: eine Systemerkrankung mit multiplen Behandlungsoptionen

Ästhetische Dermatologie & Kosmetologie, 2023-09, Vol.15 (4), p.34-41

2023

Link zum Volltext

Verfügbarkeit prüfen

Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2344589-2344589

2024

Link zum Volltext

Verfügbarkeit prüfen

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists

International journal of women's dermatology, 2023-12, Vol.9 (4), p.e112-e112

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Dermatologie (Heidelberg, Germany), 2024-05, Vol.75 (5), p.417-427

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of itch characteristics and sleep in patients with brachioradial pruritus and notalgia paresthetica: A retrospective analysis from 2 itch centers

JAAD international, 2021-03, Vol.2, p.96-97

2021

Link zum Volltext

Verfügbarkeit prüfen

33047 Simultaneous improvements in skin signs and quality of life in pediatric patients with psoriasis receiving secukinumab over 52 weeks

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB109-AB109

2022

Link zum Volltext

Verfügbarkeit prüfen

Pustulobullöse Variante eines SDRIFE (symmetrical drug-related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657

2017

Link zum Volltext

Verfügbarkeit prüfen

Entzündliche Dermatosen im Kindes- und Jugendalter: Diagnostische und therapeutische Besonderheiten anhand der atopischen Dermatitis und der Psoriasis

Die Dermatologie, 2024-04, Vol.75 (4), p.325-339

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2020-07, Vol.396 (10246), p.255-266

2020

Link zum Volltext

Verfügbarkeit prüfen

357 The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies

British journal of dermatology (1951), 2023-01, Vol.188 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Psoriasiform dermatitis in a person of colour with chronic hepatitis B

JEADV clinical practice, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

43802 Bimekizumab in patients with moderate to severe plaque psoriasis: Injection site reactions through two years of the BE RADIANT phase 3b trial and open-label extension with one-year comparison to secukinumab

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB128-AB128

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results

Journal of the American Academy of Dermatology, 2022-01, Vol.86 (1), p.122-130

2022

Link zum Volltext

Verfügbarkeit prüfen

425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies

British journal of dermatology (1951), 2023-06, Vol.188 (Supplement_3)

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial

Journal of the European Academy of Dermatology and Venereology, 2023-06, Vol.37 (S5), p.18-26

2023

Link zum Volltext

Verfügbarkeit prüfen

26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB119-AB119

2021

Link zum Volltext

Verfügbarkeit prüfen

Pustulobullous variant of SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657-659

2017

Link zum Volltext

Verfügbarkeit prüfen

Pustulobullöse Variante eines SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Journal der Deutschen Dermatologischen Gesellschaft, 2017-06, Vol.15 (6), p.657-659

2017

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory dermatoses in children and adolescents : Diagnosis and treatment of atopic dermatitis and psoriasis

Dermatologie (Heidelberg, Germany), 2024-04, Vol.75 (4), p.325-339

2024

Link zum Volltext

Verfügbarkeit prüfen

Erfolgreiche Behandlung einer generalisierten pustulösen Psoriasis mit Certolizumab

Hautarzt, 2021-11, Vol.72 (11), p.992-995

2021

Link zum Volltext

Verfügbarkeit prüfen

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

Dermatology and therapy, 2022-01, Vol.12 (1), p.203-221

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Skin (Milwood, N.Y.), 2022-11, Vol.6 (6), p.s102

2022

Link zum Volltext

Verfügbarkeit prüfen

Extensive coumarin-induced necrosis - a vasculopathy following oral anticoagulation

Journal der Deutschen Dermatologischen Gesellschaft, 2014-03, Vol.12 (3), p.263-264

2014

Link zum Volltext

Verfügbarkeit prüfen

Klinisches Management bei Pruritus

Journal der Deutschen Dermatologischen Gesellschaft, 2015-02, Vol.13 (2), p.101-116

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaPatients

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(32)
Berichte
(1)

Sprache

Englisch
(23)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Therapie der Psoriasis vulgaris: Therapiestrategien für eine optimale patientenzentrierte Versorgung

Psoriasis: eine Systemerkrankung mit multiplen Behandlungsoptionen

Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study

Gender perspective in psoriasis: a scoping review and proposal of strategies for improved clinical practice by European dermatologists

Treatment of psoriasis vulgaris : Therapy strategies for optimal patient-centered care

Comparison of itch characteristics and sleep in patients with brachioradial pruritus and notalgia paresthetica: A retrospective analysis from 2 itch centers

33047 Simultaneous improvements in skin signs and quality of life in pediatric patients with psoriasis receiving secukinumab over 52 weeks

Pustulobullöse Variante eines SDRIFE (symmetrical drug-related intertriginous and flexural exanthema)

Entzündliche Dermatosen im Kindes- und Jugendalter: Diagnostische und therapeutische Besonderheiten anhand der atopischen Dermatitis und der Psoriasis

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

357 The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies

Psoriasiform dermatitis in a person of colour with chronic hepatitis B

43802 Bimekizumab in patients with moderate to severe plaque psoriasis: Injection site reactions through two years of the BE RADIANT phase 3b trial and open-label extension with one-year comparison to secukinumab

A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results

425 Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies

Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial

26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

Pustulobullous variant of SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Pustulobullöse Variante eines SDRIFE (symmetrical drug‐related intertriginous and flexural exanthema)

Inflammatory dermatoses in children and adolescents : Diagnosis and treatment of atopic dermatitis and psoriasis

Erfolgreiche Behandlung einer generalisierten pustulösen Psoriasis mit Certolizumab

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO

Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Extensive coumarin-induced necrosis - a vasculopathy following oral anticoagulation

Klinisches Management bei Pruritus

Aktive Filter

Suchergebnisse filtern